Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Ganoderma lucidum, a type of mushroom, may help treat enlarged prostate by blocking testosterone conversion.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

The document explains the diagnosis and characteristics of woolly hair nevus and alopecia neoplastica.

Lespedeza cuneata extract may help treat enlarged prostate.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

A new compound was effective for imaging prostate cancer in rats.

Finasteride works best in 6 months and lasts 6 years.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

New compounds may soon be tested to treat excessive hair growth in women.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

SOX9 is essential for the development of various organs and hair follicles.